Literature DB >> 15880200

[Evaluation of segmentary contractility in Chagas' disease by using the integral of the myocardial velocity gradient (myocardial strain) obtained through tissue Doppler echocardiography].

Carlos Eduardo Suaide Silva1, Luiz Darcy Cortez Ferreira, Luciana Braz Peixoto, Claudia Gianini Monaco, Manuel Adán Gil, Juarez Ortiz, Bárbara Maria Ianni, José Lázaro Andrade, Wilson Mathias Júnior, Antônio Carlos Pereira Barretto.   

Abstract

OBJECTIVE: To quantify the percentage of contractility of different myocardial segments in patients with Chagas' disease by measuring myocardial strain and to assess the differences in the radial and longitudinal ventricular contractile function in the undetermined and dilated forms of chronic chagasic cardiomyopathy as compared with those in a group of healthy individuals.
METHODS: The study comprised 39 individuals [20 (51.3%) of the male sex] divided into the following 4 groups: 1) Nl: 17 (43.6%) healthy individuals; 2) Und: 7 (17.9%) patients with the undetermined form of Chagas' disease; 3) C1: 7 (17.9%) patients with the chronic form of Chagas' disease with ejection fraction < 50%; and 4) C2: 8 (20.5%) patients with the chronic form of Chagas' disease with ejection fraction > 50%. After performing baseline echocardiography, Doppler tissue images were recorded to measure myocardial strain in different segments on longitudinal and transversal parasternal, and apical 2- and 4-chamber views. RESULTS AND
CONCLUSION: The percentage of contractility in the different myocardial segments, both the radial and longitudinal components, is greater in healthy individuals than in patients with the chronic form of Chagas' disease, and in those with the undetermined form of the disease as compared with that of chronic chagasic patients with EF < 50%. Left ventricular radial contractility is greater than left ventricular longitudinal contractility in all groups (Nl, Und, and Chronic). The data presented allow us to propose a progressive character of myocardial impairment in patients with Chagas' disease.

Entities:  

Mesh:

Year:  2005        PMID: 15880200     DOI: 10.1590/s0066-782x2005000400003

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


  5 in total

1.  Indeterminate form of Chagas disease: is left ventricular torsional mechanics a clue to subclinical myocardial abnormalities?

Authors:  Marcio Silva Miguel Lima; Mariana Callil Voos; Wilson Mathias; Jeane Mike Tsutsui
Journal:  J Echocardiogr       Date:  2016-07-23

2.  Chagas cardiomyopathy: the potential of diastolic dysfunction and brain natriuretic peptide in the early identification of cardiac damage.

Authors:  Ana Garcia-Alvarez; Marta Sitges; María-Jesús Pinazo; Ander Regueiro-Cueva; Elizabeth Posada; Silvia Poyatos; José Tomás Ortiz-Pérez; Magda Heras; Manel Azqueta; Joaquim Gascon; Ginés Sanz
Journal:  PLoS Negl Trop Dis       Date:  2010-09-21

3.  Speckle tracking echocardiographic deformation indices in Chagas and idiopathic dilated cardiomyopathy: Incremental prognostic value of longitudinal strain.

Authors:  Omar Ribeiro Santos Junior; Manoel Otávio da Costa Rocha; Fernanda Rodrigues de Almeida; Pedro Ferrari Sales da Cunha; Stella Cristina Silva Souza; Gabriel Prado Saad; Thiago Adriano de Deus Queiroz Santos; Ariela Mota Ferreira; Timothy C Tan; Maria Carmo Pereira Nunes
Journal:  PLoS One       Date:  2019-08-22       Impact factor: 3.240

4.  At Last, a Sensitive Method to Detect Incipient Systolic Dysfunction!

Authors:  Carlos Eduardo Suaide Silva
Journal:  Arq Bras Cardiol       Date:  2019-11-04       Impact factor: 2.000

5.  Comprehensive left ventricular mechanics analysis by speckle tracking echocardiography in Chagas disease.

Authors:  Marcio Silva Miguel Lima; Hector R Villarraga; Maria Cristina Donadio Abduch; Marta Fernandes Lima; Cecilia Beatriz Bittencourt Viana Cruz; Marcio Sommer Bittencourt; Mariana Callil Voos; Joao Cesar Nunes Sbano; Wilson Mathias; Jeane Mike Tsutsui
Journal:  Cardiovasc Ultrasound       Date:  2016-05-27       Impact factor: 2.062

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.